EP0996457A4 - Peptides liberateurs de f.s.h. - Google Patents
Peptides liberateurs de f.s.h.Info
- Publication number
- EP0996457A4 EP0996457A4 EP98926280A EP98926280A EP0996457A4 EP 0996457 A4 EP0996457 A4 EP 0996457A4 EP 98926280 A EP98926280 A EP 98926280A EP 98926280 A EP98926280 A EP 98926280A EP 0996457 A4 EP0996457 A4 EP 0996457A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- fsh
- releasing peptides
- peptides
- releasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000005606 Activins Human genes 0.000 title 1
- 108010059616 Activins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86915397A | 1997-06-04 | 1997-06-04 | |
US869153 | 1997-06-04 | ||
PCT/US1998/011512 WO1998055136A1 (fr) | 1997-06-04 | 1998-06-03 | Peptides liberateurs de f.s.h. |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0996457A1 EP0996457A1 (fr) | 2000-05-03 |
EP0996457A4 true EP0996457A4 (fr) | 2001-09-19 |
Family
ID=25353027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98926280A Withdrawn EP0996457A4 (fr) | 1997-06-04 | 1998-06-03 | Peptides liberateurs de f.s.h. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0996457A4 (fr) |
JP (1) | JP2000513749A (fr) |
CA (1) | CA2293664A1 (fr) |
WO (1) | WO1998055136A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635740B1 (en) | 1997-03-27 | 2003-10-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Ligand/lytic peptide compositions and methods of use |
HU221407B1 (hu) | 1997-03-28 | 2002-09-28 | Gyula Magvasi | Ektodermális eredetû szövetekben fellépõ tumoros burjánzást gátló hatóanyag és készítmény, valamint eljárás elõállításukra |
DE10050831A1 (de) * | 2000-10-05 | 2002-05-02 | Veyx Pharma Gmbh | Verfahren zum Zyklusstart bei weiblichen Zuchttieren |
CN101264096B (zh) * | 2007-03-12 | 2011-11-09 | 中国医学科学院药物研究所 | 人参皂苷Rg1在制备生精产品中的应用 |
JP5764854B2 (ja) * | 2009-11-05 | 2015-08-19 | 株式会社サウスプロダクト | ポリクローナル抗体およびその利用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004927A1 (fr) * | 1994-08-10 | 1996-02-22 | Sandor Lovas | NOUVEAUX ANALOGUES DE GnRH A EFFETS ANTITUMORAUX ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721775A (en) * | 1985-08-26 | 1988-01-26 | Board Of Regents, The University Of Texas System | Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids |
US4973577A (en) * | 1986-04-04 | 1990-11-27 | The Salk Institute For Biological Studies | FSH-releasing peptides |
-
1998
- 1998-06-03 CA CA002293664A patent/CA2293664A1/fr not_active Abandoned
- 1998-06-03 JP JP11502855A patent/JP2000513749A/ja not_active Ceased
- 1998-06-03 EP EP98926280A patent/EP0996457A4/fr not_active Withdrawn
- 1998-06-03 WO PCT/US1998/011512 patent/WO1998055136A1/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004927A1 (fr) * | 1994-08-10 | 1996-02-22 | Sandor Lovas | NOUVEAUX ANALOGUES DE GnRH A EFFETS ANTITUMORAUX ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
Non-Patent Citations (6)
Title |
---|
BRAIN RESEARCH BULLETIN, vol. 25, no. 6, 1990, pages 867 - 874, ISSN: 0361-9230 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1990, YU W H ET AL: "SELECTIVE FSH-RELEASING ACTIVITY OF 9-D TRYPTOPHAN GAP-1-13 COMPARISON WITH GONADOTROPIN-RELEASING ABILITIES OF ANALOGS OF GAP AND NATURAL LHRHS", XP002170295, Database accession no. PREV199191064460 * |
MEZOE I ET AL: "SYNTHESIS OF GONADOTROPIN-RELEASING HORMONE III ANALOGS. STRUCTURE - ANTITUMOR ACTIVITY RELATIONSHIPS", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, vol. 40, October 1997 (1997-10-01), pages 3353 - 3358, XP000749516, ISSN: 0022-2623 * |
See also references of WO9855136A1 * |
SOWER S A ET AL: "PRIMARY STRUCTURE AND BIOLOGICAL ACTIVITY OF A THIRD GONADOTROPIN- RELEASING HORMONE FROM LAMPREY BRAIN", ENDOCRINOLOGY,US,BALTIMORE, MD, vol. 132, no. 3, 1993, pages 1125 - 1131, XP002067663, ISSN: 0013-7227 * |
YU WEN H ET AL: "A hypothalamic follicle-stimulating hormone-releasing decapeptide in the rat.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 94, no. 17, August 1997 (1997-08-01), 1997, pages 9499 - 9503, XP002170294, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998055136A1 (fr) | 1998-12-10 |
JP2000513749A (ja) | 2000-10-17 |
EP0996457A1 (fr) | 2000-05-03 |
CA2293664A1 (fr) | 1998-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL344341A1 (en) | Peptides | |
PL318017A1 (en) | Peptides | |
GB9719879D0 (en) | Protein | |
GB9703681D0 (en) | Protein complemention | |
GB9718110D0 (en) | Peptides | |
EP1018551A4 (fr) | Proteine megsine | |
AU1999999A (en) | Contryphan peptides | |
GB9700154D0 (en) | Peptides | |
GB9812675D0 (en) | Peptides | |
GB9714276D0 (en) | Peptides and related compounds | |
ZA984322B (en) | Sucrose-binding proteins | |
GB9425380D0 (en) | Peptides | |
EP0996457A4 (fr) | Peptides liberateurs de f.s.h. | |
GB9720784D0 (en) | Protein | |
GB9807890D0 (en) | Peptides | |
GB9613705D0 (en) | Novel peptides | |
GB9425381D0 (en) | Peptides | |
GB9713146D0 (en) | Peptides | |
GB9706556D0 (en) | Peptides | |
GB9701024D0 (en) | Peptides | |
GB9606765D0 (en) | Peptides | |
SG55039A1 (en) | Peptides | |
GB9626362D0 (en) | Peptides | |
GB9625227D0 (en) | Peptides | |
GB9612648D0 (en) | Peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19991223 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 38/08 A, 7C 07K 7/23 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010806 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020422 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20031203 |